Generate Biomedicines, Inc. (GENB)
14.34
+0.36
(+2.54%)
USD |
NASDAQ |
Oct 09, 16:00
14.34
0.00 (0.00%)
After-Hours: 20:00
Generate Biomedicines EPS Diluted (Quarterly) : -0.5243 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.5243 |
| March 31, 2026 | -0.5398 |
| Date | Value |
|---|---|
| June 30, 2025 | -1.939 |
| March 31, 2025 | -1.616 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Twist Bioscience Corp. | -0.5617 |
| Intellia Therapeutics, Inc. | -0.7989 |
| Prime Medicine, Inc. | -0.2376 |
| Moderna, Inc. | -1.965 |
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -67.26M |
| Revenue (Quarterly) | 6.314M |
| Total Expenses (Quarterly) | 73.57M |
| Enterprise Value | 1.400B |
| Gross Profit Margin (Quarterly) | 48.94% |
| Profit Margin (Quarterly) | -1.07K% |
| Earnings Yield | -32.20% |
| Normalized Earnings Yield | -32.18 |